---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-000862"
form_type: "8-K"
ticker: "EDIT"
cik: "0001650664"
company_name: "Editas Medicine, Inc."
filed_at: "2022-02-07T23:59:59+00:00"
generated_at: "2026-06-27T10:40:25.362116+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Editas Medicine terminates CMO Lisa Michaels effective immediately

## Summary
- Lisa Michaels' employment as Chief Medical Officer terminated on February 7, 2022.
- Severance includes base salary for 12 months, COBRA contributions, and unpaid prior bonus.
- Payments contingent on signing and compliance with severance and release agreement.
- No successor appointed; CEO James Mullen signed the filing.

## SEC filing metadata
- accession: 0001558370-22-000862
- form_type: 8-K
- ticker: EDIT
- cik: 0001650664
- company_name: Editas Medicine, Inc.
- filed_at: 2022-02-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1650664/000155837022000862/0001558370-22-000862-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1650664/000155837022000862/edit-20220207x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-000862
- JSON: https://secwatch.observer/filing/0001558370-22-000862.json
- Plain text: https://secwatch.observer/filing/0001558370-22-000862.txt

## Key facts
- Executive change
  Lisa Michaels was terminated as Chief Medical Officer at Editas Medicine, Inc..
  - Action: terminated
  - Role: Chief Medical Officer
  source text: On February 7, 2022, Lisa Michaels’ employment with Editas Medicine, Inc. (the “Company”) as Chief Medical Officer was terminated, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1650664/000155837022000862/0001558370-22-000862-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.